News Pharma Industry

Covishield: As Covaxin, Covishield pass gruelling scrutiny, India’s Vaccine Maitri gets a shot in the arm

[ad_1]

Concept by Vikas Dandekar and Muhabit ul haq

Synopsis

As the pandemic gripped the world, global vaccine makers led the battle against the virus. For Indian firms, it was only the beginning of a volley of challenges. Even as they managed to dole out millions of jabs, allegations flew thick and fast. However, with the cloud of uncertainty disappearing, they seem all set to make a big splash.

“First they ignore you. Then they ridicule you. And then they attack you and want to burn you. And then they build monuments to you.”— Nicholas Klein. The American labour union advocate’s inspiring words in a 1918 address to the Amalgamated Clothing Workers in Baltimore, often misattributed to Mahatma Gandhi, have an uncanny relevance in today’s world. For Indian vaccine makers, Serum Institute of India and Bharat Biotech, the last 21 months

  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • PRINT
  • COMMENT

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Great New Year Sale

GET FLAT 30% OFF

On ET Prime & stay ahead of the rest in 2022

Get Offer

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

[ad_2]

Source link